5 completed. 4 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Not applicable | 1 | Completed 1 |
Follow Ethinylestradiol: new trials by email Literature Review of Ethinylestradiol trials Research Report on Ethinylestradiol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Milvexian in Healthy Adult Females Milvexian, Midazolam, Ethinylestradiol - Healthy Female | Phase 1 | Completed | Janssen Pharmaceutica N.V., Belgium | 20 | 2023-01-25 | 2025-03-30 |
| A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone Ethinylestradiol, Norethindrone, JNJ-63623872 - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 18 | 2015-12-01 | 2016-06-06 |
| Phlebotomy and Polycystic Ovary Syndrome Phlebotomy, ethinylestradiol, Cyproterone Acetate - Hyperandrogenism, Metabolic Cardiovascular Syndrome | Not applicable | Completed | Manuel Luque Ramírez | 37 | 2015-01-01 | 2022-07-27 |
| Drug-drug Interaction of BI 201335 and Microgynon levonorgestrel, Ethinylestradiol, BI 201335 - Hepatitis C, Chronic | Phase 1 | Completed | Boehringer Ingelheim | 16 | 2012-04-01 | 2015-08-03 |
| Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon levonorgestrel, Ethinylestradiol, Microgynon + BI 10773 - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 18 | 2011-04-01 | 2014-06-18 |
Hepatitis C, Chronic (1) · Hyperandrogenism (1) · Insulin Resistance (1) · Metabolic Syndrome (1) · Polycystic Ovary Syndrome (1) · Primary Dysautonomias (1)
Boehringer Ingelheim (2) · Janssen Pharmaceutica N.V., Belgium (1) · Janssen Research & Development, LLC (1) · Manuel Luque Ramírez (1)
Belgium (2) · Germany (2) · Spain (1)
PMID 23512637, PMID 25385099, PMID 33462622, PMID 34764381, PMID 35807149
2015 (1)